Release Date: 20/08/09 09:41 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 12.22KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%